Description

With decreasing profit margins, increasing cost pressures, growing regulatory compliance concerns, mounting pressure from generic drugs and increasing anxiety about the future of healthcare reimbursement, pharmaceutical manufacturers are now forced to re-examine and re-assess the way they have been doing things. In order to sustain profitability, these companies are looking to reduce waste (of all kinds), improve efficiency and increase productivity. Many of them are taking a closer look at lean manufacturing as a way to achieve these goals. Lean biomanufacturing re-visits lean principles and then applies them sympathetically - in a highly practical approach - to the specific needs of pharmaceutical processes, which present significantly different challenges to more mainstream manufacturing processes. A major goal of the book is to highlight those problems and issues that appear more specific or unique to biopharmaceutical manufacturing situations and to provide some insights into what challenges are the important ones to solve and what techniques, tools and mechanisms to employ to be successful.

Following an introduction to lean biomanufacturing, the book goes on to discuss lean technologies and methods applied in biomanufacturing. Later chapters cover the creation and implementation of the Transition Plan, issues facing the biopharmaceutical industry, creating a lean approach towards biopharmaceutical processes and the contribution of simulation models in developing these processes. The final chapter covers examples of new technology innovations which help facilitate lean biomanufacturing.

Key Features

  • A focus on the issues associated with the application of lean principles to biomanufacturing
  • Practical examples of factors which can affect biopharmaceutical processes
  • Coverage of key factors which require integration to run an efficient biopharmaceutical process

Readership

Vaccine manufacturers; Operational managers in the fields of biotechnology and biopharmaceutical industries

Table of Contents

Dedication

Foreword

List of figures

List of tables

Acknowledgements

About the author

Chapter 1: An introduction to Lean biomanufacturing

Abstract:

1.1 What is Lean?

1.2 Muda, muda, muda – the seven forms of waste

1.3 Creation of value through the application of Lean

1.4 SIPOC analysis

1.5 Flow charting

1.6 Pull versus push; a change in paradigm for Lean production

1.7 Benefits of a pull strategy

1.8 Considering cost issues

1.9 New approaches to manufacturing

1.10 The driving force for innovation

Chapter 2: Lean technologies/methods to be applied to biomanufacturing

Abstract:

2.1 Some key thoughts

2.2 Box score

2.3 Some key points

2.4 Members of the value stream mapping team

2.5 Where to start?

2.6 Tools

2.7 Mapping the process

2.8 Value stream mapping and identifying waste

2.9 DMAIC – Define Measure Analyze Improve Control

2.10 PDCA – Plan Do Check Act

2.11 Kaizen events/Kaizen blitz

2.12 Tracing the root cause of waste

2.13 The 5S tool

2.14 Transition Plan: translation of the current state to a new state Transition Plan

2.15 Cultural changes and the importance of change management as a key component of Lean manufacturing/Lean enterprise initiatives

2.16 Change management and culture transition

2.17 Cycle time reduction

2.18 Increasing throughput

2.19 Process flow implementation and control of variability

2.20 Control of downtime

2.21 Pull system implementation

2.22 Reduction of work in progress

Chapter 3: Creation, execution and implementation of the Transition Plan

Abstract:

3.1 Background

3.2 The Analytics Phase

3.3 Value stream mapping

3.4 Important tools for implemen

Details

No. of pages:
384
Language:
English
Copyright:
© 2013
Published:
Imprint:
Woodhead Publishing
eBook ISBN:
9781908818409
Print ISBN:
9781907568787

About the author

Nigel Smart

Nigel J. Smart PhD is a 30 year veteran of the biotechnology industry who has spent his career involved in developing and manufacturing numerous recombinant protein, monoclonal antibody and vaccine products. He holds a BSc from the University of Leicester, and an MSc and PhD in Fermentation Technology/Biochemical Engineeringfrom the University of Manchester. His career has spanned academia, Big Pharma and progressive biotechnology companies involved in cutting-edge biopharmaceutical products. For the last eleven years he has been a much sought-after consultant solving operational problems and compliance related issues to the pharmaceutical and biopharmaceutical industry. This has also included advising the US government on manufacturing strategies to produce a variety of biological countermeasures for the biodefense program. As Managing Partner of Smart Consulting Group, Dr Smart is now a proponent of lean approaches to biopharmaceutical manufacturing processes and leads the company’s business team in this area.

Affiliations and Expertise

Smart Consulting Group, USA